| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.13 | 0.4 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.11 | 0.4 |